Prevention of coronary heart disease in clinical practice: A commentary on current treatment patterns in six european countries in relation to published recommendations

Cardiology (Switzerland)

Volumn 87, Issue 1, 1996, Pages 1-5

  Shepherd, J ^a   Pratt, M ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b Taylor Nelson AGB Healthcare   (United Kingdom)

Author keywords

Cholesterol; Coronary heart disease; Epidemiology

Indexed keywords

CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CORONARY RISK; EUROPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MASS SCREENING; NORMAL HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029655739     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177051     Document Type: Article

References (11)

1. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-1331.
2. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
3. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 1994;89:1329-1445.
4. International Task Force for Prevention of Coronary Heart Disease: Prevention of coronary heart disease: Scientific background and new clinical guidelines. Recommendations of the European Atherosclerosis Society prepared by the International Task Force for Prevention of Coronary Heart Disease. Nutr Mctab Car-diovascDis 1992;2:113-156.
5. Recommendaciones de ILIB para el diagnostico de las dislipidemias en Latinoamérica: Panel de expertos en detección, evaluación y tratamiento de dislipidemias del International Lipid Information Bureau (ILIB) Latino América. Cardiovasc Risk Factors 1994;3(suppl 1): 10-27.
6. Bcttcridgc DJ. Dodson PM, Durrington PN, et al: Management of hyperlipidaemia: Guidelines of the British Hyperlipidaemia Association. Postgrad Med J 1993;69:359-369.
7. Report of the Canadian Cardiovascular Society's Consensus Conference on the Management of the Postmyocardial Infarction Patient. Can Med Assoc J 1991; 144:1015-1025.
8. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, Buring GT, Hennekens CH: The primary prevention of myocardial infarction. N Engl J Med 1992;326: 1406-1416.
9. Bartechi CE, MacKenzie TD, Schrier RW: The human costs of tobacco use (first of two parts). N Engl J Med 1994;330:907-912.
10. MacKenzie TD. Bartechi CE, Schrier RW: The human costs of tobacco use (second of two parts). N Engl J Med 1994;330:975-980.
11. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.